Solara Active Pharma Sciences to incorporate wholly owned subsidiary
07 - Feb - 2025 12:00 | 52 days ago
Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in relation to proposed demerger of the CRAMS and Polymers Business into an independent listed entity.
Solara Active Pharma Sciences to incorporate wholly owned subsidiary
07 - Feb - 2025 12:00 | 52 days ago
Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in relation to proposed demerger of the CRAMS and Polymers Business into an independent listed entity.
Solara Active Pharma Sciences reports consolidated net profit of Rs 8.09 crore in the December 2024 quarter
24 - Jan - 2025 12:00 | 66 days ago
Net profit of Solara Active Pharma Sciences reported to Rs 8.09 crore in the quarter ended December 2024 as against net loss of Rs 275.34 crore during the previous quarter ended December 2023. Sales rose 41.70% to Rs 300.31 crore in the quarter ended December 2024 as against Rs 211.94 crore during the previous quarter ended December 2023.
Solara Active Pharma Sciences to incorporate wholly owned subsidiary
07 - Feb - 2025 12:00 | 52 days ago
Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in relation to proposed demerger of the CRAMS and Polymers Business into an independent listed entity.
Solara Active Pharma Sciences reports consolidated net profit of Rs 8.09 crore in the December 2024 quarter
24 - Jan - 2025 12:00 | 66 days ago
Net profit of Solara Active Pharma Sciences reported to Rs 8.09 crore in the quarter ended December 2024 as against net loss of Rs 275.34 crore during the previous quarter ended December 2023. Sales rose 41.70% to Rs 300.31 crore in the quarter ended December 2024 as against Rs 211.94 crore during the previous quarter ended December 2023.
Solara Active Pharma Sciences to incorporate wholly owned subsidiary
07 - Feb - 2025 12:00 | 52 days ago
Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in relation to proposed demerger of the CRAMS and Polymers Business into an independent listed entity.
Solara Active Pharma Sciences to incorporate wholly owned subsidiary
07 - Feb - 2025 12:00 | 52 days ago
Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in relation to proposed demerger of the CRAMS and Polymers Business into an independent listed entity.
Solara Active Pharma Sciences reports consolidated net profit of Rs 8.09 crore in the December 2024 quarter
24 - Jan - 2025 12:00 | 66 days ago
Net profit of Solara Active Pharma Sciences reported to Rs 8.09 crore in the quarter ended December 2024 as against net loss of Rs 275.34 crore during the previous quarter ended December 2023. Sales rose 41.70% to Rs 300.31 crore in the quarter ended December 2024 as against Rs 211.94 crore during the previous quarter ended December 2023.